{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T05:27:12Z","timestamp":1738992432110,"version":"3.37.0"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1645,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1002\/hep.23986","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T23:40:09Z","timestamp":1293061209000},"page":"1068-1069","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Effects of Beta-Blockers on Survival for Patients With Cirrhosis and Refractory Ascites \u0394"],"prefix":"10.1097","volume":"53","author":[{"given":"Gin-Ho","family":"Lo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-55-20250207","doi-asserted-by":"crossref","first-page":"10171022","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of betablockers on survival in patients with cirrhosis and refractory ascites.","volume":"52","author":"Serste","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R2-55-20250207","doi-asserted-by":"crossref","first-page":"811813","DOI":"10.1002\/hep.23852","article-title":"Betablockers in cirrhosis: friend and foe?","volume":"52","author":"Wong","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R3-55-20250207","doi-asserted-by":"crossref","first-page":"20872107","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update.","volume":"49","author":"Runyon","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R4-55-20250207","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/hep.23140","article-title":"The management of cirrhotic ascites.","volume":"50","author":"Lo","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R5-55-20250207","doi-asserted-by":"crossref","first-page":"13711374","DOI":"10.1056\/NEJM198112033052302","article-title":"Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.","volume":"305","author":"Lebrec","year":"1981","journal-title":"N Engl Med"},{"key":"R6-55-20250207","doi-asserted-by":"crossref","first-page":"580587","DOI":"10.1002\/hep.22358","article-title":"Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding.","volume":"48","author":"Lo","year":"2008","journal-title":"HEPATOLOGY"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23986","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201103000-00055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:58:55Z","timestamp":1738947535000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201103000-00055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23986","relation":{},"ISSN":["0270-9139"],"issn-type":[{"type":"print","value":"0270-9139"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}